A Phase 2, Randomized, Multicenter, Placebo-Controlled, Proof-of-Concept Trial of Oral Fexinidazole in Adults With Chronic Indeterminate Chagas Disease

dc.contributor.authorFaustino Torrico
dc.contributor.authorJoaquím Gascón
dc.contributor.authorLourdes Ortiz
dc.contributor.authorJimy Pinto
dc.contributor.authorGimena Rojas
dc.contributor.authorAlejandro Palacios
dc.contributor.authorFabiana Barreira
dc.contributor.authorBethania Blum
dc.contributor.authorAlejandro G. Schijman
dc.contributor.authorMichel Vaillant
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T13:57:01Z
dc.date.available2026-03-22T13:57:01Z
dc.date.issued2022
dc.descriptionCitaciones: 51
dc.description.abstractNCT02498782.
dc.identifier.doi10.1093/cid/ciac579
dc.identifier.urihttps://doi.org/10.1093/cid/ciac579
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/43667
dc.language.isoen
dc.publisherOxford University Press
dc.relation.ispartofClinical Infectious Diseases
dc.sourceUniversity of San Simón
dc.subjectMedicine
dc.subjectPlacebo
dc.subjectIndeterminate
dc.subjectMulticenter trial
dc.subjectChagas disease
dc.subjectRandomized controlled trial
dc.subjectMulticenter study
dc.subjectInternal medicine
dc.subjectIntensive care medicine
dc.titleA Phase 2, Randomized, Multicenter, Placebo-Controlled, Proof-of-Concept Trial of Oral Fexinidazole in Adults With Chronic Indeterminate Chagas Disease
dc.typearticle

Files